# PEX010-Assisted Therapy for Stimulant Use Disorder: A Safety, Feasibility and Efficacy Study

> **NCT06666010** · PHASE2 · NOT_YET_RECRUITING · sponsor: **Filament Health Corp.** · enrollment: 86 (estimated)

## Conditions studied

- Stimulant Use Disorder

## Interventions

- **DRUG:** PEX010-Assisted Therapy
- **DRUG:** PEX010(01)

## Key facts

- **NCT ID:** NCT06666010
- **Lead sponsor:** Filament Health Corp.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-01
- **Primary completion:** 2028-01
- **Final completion:** 2028-07
- **Target enrollment:** 86 (ESTIMATED)
- **Last updated:** 2024-10-30

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06666010

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06666010, "PEX010-Assisted Therapy for Stimulant Use Disorder: A Safety, Feasibility and Efficacy Study". Retrieved via AI Analytics 2026-08-13 from https://api.ai-analytics.org/clinical/NCT06666010. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*